FEATURESFeasibility of the Korean-Advance Directives Among Community-Dwelling Elderly PersonsKim, Shinmi PhD, RN; Hong, Sun Woo PhD, RN; Kim, JinShil PhD, RNAuthor Information Department of Nursing, Changwon National University, Gyeongsangnam-do, Korea (Dr Shinmi Kim); Department of Emergency Medical Services, Daejeon University, Daejeon, South Korea (Dr Hong); and College of Nursing, Gachon University, Incheon, South Korea (Dr JinShil Kim). Correspondence: JinShil Kim, PhD, RN, College of Nursing, Gachon University, 191 Hambakmoero, Yeonsu-gu, Incheon, South Korea ([email protected]). Financial support for this study was provided by the National Research Foundation of Korea fund of the Korean Government (grant #2010-0021379).There is no conflict of interest to declare. Holistic Nursing Practice: July/August 2017 - Volume 31 - Issue 4 - p 234-242 doi: 10.1097/HNP.0000000000000216 Buy Metrics Abstract A newly developed Korean-Advance Directive (K-AD) consists of a value statement, treatment directives, and proxy appointment. It remains undetermined whether K-AD is applicable to community-dwelling persons (≥ aged 60 years). Using a descriptive study design, 275 elderly persons completed the K-AD (mean age = 77.28 ± 8.24 years). The most frequent value at the end of life was comfort dying, followed by no burden to family (23.6%). Among 4 K-AD treatment options, more than half had a preference for hospice care and had reluctance with aggressive treatment choices of cardiopulmonary resuscitation (76.4%), artificial ventilation (75.6%), and tube feeding (76.4%), with one-fifth having a desire for such options. All persons provided proxies, who were predominantly descendants (77.1%), followed by spouses (17.5%). For treatment preferences, men and those with no religion were more likely to receive life-sustaining treatments. These data support the K-AD as being applicable and acceptable among community-dwelling elderly persons; awareness of the K-AD in the community setting may facilitate future application when the need occurs. © 2017 Wolters Kluwer Health, Inc. All rights reserved.